ENTITY
Sysmex

Sysmex (6869 JT)

6
Analysis
Health Care • Japan
SYSMEX CORPORATION manufactures reagents and equipment for clinical tests including hematologic (blood) and immune tests. The Company also develops, manufactures, and trades particle analyzers such as blood coagulation analyzer and related software. Manufacturing and sales outside Japan include the United States, EMEA, China and Asia Pacific regions.
more
•03 Jun 2026 16:46

Mindray (迈瑞医疗) A+H Pre-IPO: Early Thoughts

Mindray is seeking to raise at least USD500m through an A+H listing. The note covers business quality, industry context, peer valuation, and A-H...

Logo
156 Views
Share
•31 May 2026 18:51

MS-Japan June 2026 Rebalance: Pre-Implementation Update

MS-Japan enters the implementation phase on 1 June 2026. We update stock performance and discuss implementation trades.

Logo
182 Views
Share
•28 May 2026 07:08

Global Index: Potential Changes in May for Asia Pac

The index rebalances at the close tomorrow and there will be huge volume in the constituent changes at the close. Since announcement, the adds have...

Logo
611 Views
Share
•27 May 2026 10:52

KHI (7012 JP): Progress with Physical AI

KHI opened a Physical AI Center in San Jose, where it will collaborate with Nvidia, Analog Devices, Microsoft and Fujitsu. It is also working with...

Logo
167 Views
Share
•11 Nov 2018 02:11

High Beta and Names with a High % of Foreign Investors Underperformed This Week in Japan....

In Japan, high Beta names and names with a high % of Foreign Investors underperformed this week after doing very well the previous week. It has...

Share
x